|
Press Releases |
|
 |
|
Tuesday, October 24, 2017 |
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
Tuesday, August 15, 2017 |
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
Thursday, June 15, 2017 |
|
First-Year Performance of Global Systematic Multi-Strategy Fund |
The Board of Directors of Singapore eDevelopment Ltd ("SeD") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation. more info >> |
|
Monday, May 22, 2017 |
|
Singapore eDevelopment's Global BioLife Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Ltd ("SeD"), through its subsidiary Global BioLife Inc. ("Global BioLife"), has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee, Mr Daryl Thompson. more info >> |
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition - New Designs Added for Admission Bonus Illustration Cards
Jul 16, 2025 11:00 JST
|
|
|
Formerra 將在美洲地區供應 Foster 醫用化合物
Jul 16, 2025 09:20 HKT/SGT
|
|
|
Formerra 将在美洲地区供应 Foster 医用化合物
Jul 16, 2025 09:20 HKT/SGT
|
|
|
AATec Medical 與 Northway Biotech 宣布合作開發用於治療肺部疾病的 ATL-105 工業化生產工藝
Jul 16, 2025 09:00 HKT/SGT
|
|
|
AATec Medical 与 Northway Biotech 宣布合作开发用于治疗肺部疾病的 ATL-105 工业化生产工艺
Jul 16, 2025 09:00 HKT/SGT
|
|
|
maxWin Sports Makes It Debut in Motorsports with EBM-GIGA Racing Team
Jul 16, 2025 09:00: JST
|
|
|
maxWin Sports Makes It Debut in Motorsports with EBM-GIGA Racing Team
Jul 16, 2025 08:00 HKT/SGT
|
|
|
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 23:54 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup
Jul 15, 2025 23:14 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 23:13 HKT/SGT
|
|
|
Formerra to Supply Foster Medical Compounds Across the Americas
Jul 15, 2025 22:50 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 15, 2025 20:06 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 15, 2025 19:41 HKT/SGT
|
|
|
Ocean One Seizing Business Opportunities with Main Board Listing Application
Jul 15, 2025 19:00 HKT/SGT
|
|
|
大洋環球申轉主板上市捉緊商機 迎中國恢復部分日本水產進口機遇
Jul 15, 2025 18:22 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|